AIM ImmunoTech (AIM) Accumulated Depreciation & Amortization (2018 - 2024)
Historic Accumulated Depreciation & Amortization for ImmunoTech (AIM) over the last 9 years, with Q3 2024 value amounting to $1.3 million.
- ImmunoTech's Accumulated Depreciation & Amortization fell 493.31% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.3 million, marking a year-over-year decrease of 493.31%. This contributed to the annual value of $1.3 million for FY2023, which is N/A changed from last year.
- As of Q3 2024, ImmunoTech's Accumulated Depreciation & Amortization stood at $1.3 million, which was down 493.31% from $1.3 million recorded in Q2 2024.
- In the past 5 years, ImmunoTech's Accumulated Depreciation & Amortization registered a high of $9.0 million during Q3 2020, and its lowest value of $1.3 million during Q4 2023.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $1.4 million (2023), whereas its average is $3.9 million.
- As far as peak fluctuations go, ImmunoTech's Accumulated Depreciation & Amortization skyrocketed by 892.05% in 2020, and later tumbled by 3496.84% in 2024.
- Quarter analysis of 3 years shows ImmunoTech's Accumulated Depreciation & Amortization stood at $9.0 million in 2020, then crashed by 85.4% to $1.3 million in 2023, then increased by 2.12% to $1.3 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $1.3 million for Q3 2024, versus $1.3 million for Q2 2024 and $1.3 million for Q1 2024.